Biosourced Au(III) Complexes from D‐Xylose: Synthesis and Biological Evaluation
A series of xylose‐based ligands was obtained using a convenient approach, in a few steps from D‐xylose. The complexation properties of these ligands towards Au3+ cations have been studied through different methods (multinuclear NMR, mass spectrometry, elemental analysis). The biological properties...
Saved in:
Published in | ChemMedChem Vol. 20; no. 3; pp. e202400565 - n/a |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
WEINHEIM
Wiley
01.02.2025
Wiley Subscription Services, Inc Wiley-VCH Verlag |
Subjects | |
Online Access | Get full text |
ISSN | 1860-7179 1860-7187 1860-7187 |
DOI | 10.1002/cmdc.202400565 |
Cover
Summary: | A series of xylose‐based ligands was obtained using a convenient approach, in a few steps from D‐xylose. The complexation properties of these ligands towards Au3+ cations have been studied through different methods (multinuclear NMR, mass spectrometry, elemental analysis). The biological properties (antibacterial and anti‐tumoral) of all the isolated xyloside Au(III) complexes were investigated in vitro. The xyloside Au(III) complexes gave the highest activities against E. coli (vs P. aeruginosa, S. aureus and S. epidermidis). The study also revealed that the nature of the sugar may play an important role in determining the selectivity of the antibacterial effect. Preliminary anti‐tumoral evaluations showed that one complex containing a polyamine chain, exhibited interesting anti‐proliferative activities on breast tumor cell lines MDA‐MB‐231 and BT‐20. The anti‐migratory effect of this complex also showed an average 35 % reduction in cell migration on the same two cancer cell lines.
A series of biosourced Au(III) complexes was prepared by efficient procedures from D‐xylose. Their ability to inhibit bacterial growth was evaluated on 4 bacterial strains (S. aureus, S. epidermidis, P. aeruginosa and E. coli). Their cytotoxicity and anti‐migratory properties was explored on 2 human mammary adenocarcinomas (MDA‐MB‐231 and BT‐20). |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 1860-7179 1860-7187 1860-7187 |
DOI: | 10.1002/cmdc.202400565 |